IPipeline partners with ICover to optimise insurance buying experience

IPipeline has entered into a strategic partnership in the US with ICover, an insurtech provider of algorithmic underwriting for streamlining the assessment, pricing, and delivery of life insurance.

This strategic alliance aims to benefit both platforms—with ICover helping to strengthen IPipeline’s existing automated capabilities within its Resonant solution—to create a quicker life insurance sales cycle.

ICover, which will be available via IPipeline’s IGO e-App, uses artificial intelligence (AI) predictive modelling to assess mortality risk, reducing the digital consumer application process to five minutes—and producing fully underwritten offers without labs, exams, or attending physician statements.

The agreement will aim to benefit IPipeline users by offering them:

Deane Price, chief executive officer of IPipeline, said: “As the demand for AI-driven automated medical underwriting grows, we have partnered with an innovative and progressive AI provider to create an even faster end-to-end selling process.

“The combination of IPipeline and ICover will automate and simplify a process which can normally take weeks, while increasing sales and lowering overhead.

“This is a game-changing enhancement for the life insurance industry, and we are proud to offer it in our ecosystem.”

Hari Srinivasan, founder and CEO of ICover, added: “We built a powerful decision framework that has revolutionized underwriting.

“Working together with IPipeline, we can help insurers expand their reach and sell to a greater number of customers through a seamless, digital experience that just takes a few minutes.”

Exit mobile version